CNS Pharmaceuticals (CNSP) announced the appointment of Lynne Kelley, MD, FACS, as Chief Medical Officer. Prior to joining CNS Pharmaceuticals, Dr. Kelley served as CMO at multiple public and private biotechnology and medical device companies, including TISSIUM, Servier Pharmaceuticals, X4 Pharmaceuticals and Senseonics.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNSP:
- CNS Pharmaceuticals Restructures Finance Leadership, Appoints New CFO
- CNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO
- CNS Pharmaceuticals says priority ‘is to transform’ how company operates
- CNS Pharmaceuticals Inc trading resumes
- CNS Pharmaceuticals Inc trading halted, volatility trading pause